Watch for Continued Gains in Shares of Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

July 16, 2021 10:52:41

Shares of Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) traded today at $123.59, eclipsing its 52-week high. This new high was reached on below average trading volume as 214,000 shares traded hands, while the average 30-day volume is approximately 894,000 shares.

Biohaven Pharmaceutical Holding Company Ltd. share prices have moved between a 52-week high of $123.59 and a 52-week low of $57.66 and are now trading 114% above that low price at $123.29 per share.

Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) is currently priced 26.9% above its average consensus analyst price target of $90.11.

Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV-3100, BHV5000, BHV5500, among others.

Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected

About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer